Stockscreener 앱 받기
0.6102
0.78%
-0.0048
Generation Bio Co 주식(GBIO)의 최신 뉴스
Generation Bio stock hits 52-week low at $0.6 amid sharp decline - Investing.com
Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing - EU-Startups
Layoff Tracker: Kojin Will Soon Close Its Doors, Affecting 25 Employees - BioSpace
Generation Bio stock hits 52-week low at $0.66 By Investing.com - Investing.com Nigeria
Generation Bio stock hits 52-week low at $0.66 - MSN
Insider Buying: Quinn Anthony G., Generation Bio Co [GBIO] Director invested 125,791 shares - Knox Daily
BBAI Stock Sees Surge of Approximately 95.33% in Last Five Days - Knox Daily
Insider Selling: Les Jason, Riot Platforms Inc [RIOT] CHIEF EXECUTIVE OFFICER divested 50,000 shares - Knox Daily
Biotech Executive Powerhouse: Ex-Generation Bio CFO Takes Dual Leadership Role at Rising ADC Developer Tubulis - StockTitan
Pioneering the next generation of bio-based polymers in partnership with London-listed Synthomer - University of York
Ratio Revelations: Generation Bio Co (GBIO)’s Financial Metrics in the Spotlight - The Dwinnex
Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat
3 US Penny Stocks With Market Cap Under $70M - Yahoo Finance
Generation Bio Co. (NASDAQ:GBIO) Shares Purchased by Barclays PLC - Defense World
Generation Bio chief scientific officer Matthew Stanton to leave role - MSN
Analysts Provide Insight Into Generation Bio Co’s (GBIO) Potential. - Stocks Register
Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely? - Yahoo Finance
Generation Bio Independent Director Acquires 131% More Stock - Yahoo Finance
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Jane Street Group LLC - Defense World
Generation Bio director Quinn Anthony buys $203k in shares By Investing.com - Investing.com South Africa
Generation Bio Co. (NASDAQ:GBIO) Director Anthony G. Quinn Purchases 125,791 Shares - MarketBeat
Anthony G. Quinn Purchases 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat
Generation Bio director Quinn Anthony buys $203k in shares - Investing.com
Seattle immunotherapy startup Umoja Biopharma raises $100M - GeekWire
Needham & Company LLC Issues Pessimistic Forecast for Generation Bio (NASDAQ:GBIO) Stock Price - Defense World
Generation Bio's SWOT analysis: ctLNP tech drives pivot to autoimmune stock - Investing.com Canada
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies - Business Wire
Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights
Needham & Company LLC Lowers Generation Bio (NASDAQ:GBIO) Price Target to $8.00 - MarketBeat
Barclays PLC Boosts Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Novo Nordisk partners with Variant Bio; Aviceda raises $207M in Series C - Endpoints News
Generation Bio Announces Executive Departures and Appointments - Defense World
Generation Bio Restructures Leadership and Focuses on siRNA - TipRanks
Generation Bio Co. Announces Executive Changes - Marketscreener.com
Generation Bio Co. to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - Marketscreener.com
0.27%
3.05%
자본화:
|
볼륨(24시간):